Table: Kaken Pharmaceutical -Q1 group results

KAKEN PHARMACEUTICAL

01/08/2019 05:30

Aug 1 (Reuters)- 
             Kaken Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2019        Jun 30, 2018     Mar 31, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             22.34               24.14            92.90    
                 (-7.5 pct)          (-3.3 pct)       (-1.3 pct)  
  Operating          6.71                5.65            22.30    
                 (+18.7 pct)         (-26.2 pct)      (-9.3 pct)  
  Recurring          6.90                5.82            22.70    
                 (+18.6 pct)         (-25.6 pct)      (-9.1 pct)  
  Net                4.83                4.04            16.10    
                 (+19.6 pct)         (-26.1 pct)      (-9.4 pct)  
  EPS            121.65 yen          100.16 yen       409.48 yen  
  Ann Div                            150.00 yen       150.00 yen  
  -Q2 div                             75.00 yen        75.00 yen  
  -Q4 div                             75.00 yen        75.00 yen  
  
  NOTE - Kaken Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T